COVID-19 Testing

Short Description:

Used For Covid-19 antigen/antibody/vaccine titer test
Specimen Front of nasal/Throat/Nasal/Saliva/Serum/Plasma/Whole blood
Certification CE/ISO13485/White List/PEI certified
MOQ 1000 test kits
Delivery time 1 week after Get payment
Packing 1 test kits/Packing box;5 test kits/packig box;20 test kits/packing box
Test Data Over 95% Sensitivity and Specificity
Shelf Life 2 years
Production Capacity 1 Million/Week
Payment T/T, Western Union, Paypal


Product Detail

Product Tags

COVID-19 Antigen Test

 

Test Sample Accuracy
Front of nasal 98.98%
Saliva 94.62%
Throat 99.35%
Nasal 96.67%

Remarks: all antigen test are avaliable in boxes of 1 test, 5 tests and 20 tests 

Certificates

1.CE/ISO13485

2. Bfarm listed for professional and self Test kits

3. PEI

4. Registered in Germany/Italy/Austra/Poland/Argentina/Malaysia/Indonesia and etc.

COVID TEST  (2)

COVID TEST  (1)

 

COVID-19 Neutralizing Antibody Test

( It can be matched with quantitative detection of strip reader)

A rapid test for the Qualitative or quantitative detection of the neutralizing antibodies to the SARS-CoV-2 or its vaccines in whole blood, serum, or plasma.

The resultif carrying COVID-19 vaccination are expected to be like below.

- Before first dose: Negative by rapid test

- 3 weeks after first dose: weak or middle positive

- 1 week after second dose: middle or high positive

- 2 weeks after second dose: middle or high positive

图片1

 

Sense of quantitative and qualitative result.

Qualitative (compare the intensity of T line with the C line) Reference value (Quantitative)
Negative The line T is darker
than that of line C
Nab < 50ng/ml
Low titer The line T is equal to or slightly lighter than line C 50ng/ml ≤ Nab ≤ 300ng/ml
Middle titer The line T is apparently
lighter than line C
300ng/ml < Nab ≤1000ng/ml
High titer The line T is very
light or colorless
Nab >= 1000ng/ml

Neutralizing antibody test

vaccine titer test

 

 

COVID-19 IgG/IgM Antibody Test

A rapid test for the qualitative detection of antibodies (IgG and IgM) to the novel coronavirus COVID-19 in whole blood, serum, or plasma.

PRINCIPLE

The Coronavirus COVID-19 IgG/IgM Antibody Rapid Test is for detection of IgG and IgM antibodies to COVID-19 virus. Anti-human IgG and anti-ligand are separately coated in the test line region 1 and region 2. During testing, the specimen reacts with COVID-19 antigen-coated particles in the test strip. The mixture then migrates upward on the membrane chromatographically by capillary action and reacts with the anti-human IgG and the ligand anti-human IgM. COVID-19 IgG or IgM antibodies, if present in the specimen, reacts with the anti-human IgG in region 1 or the ligand anti-human IgM. The complex is captured and forming a colored line in the Test line region 1 or 2.

The Coronavirus COVID-19 IgG/IgM Antibody Rapid Test contains COVID-19 antigen-coated particles. Anti-human IgG and anti-human IgM are coated in the test line regions.

covid-19 igg/igm

IMMONO

 

 

COVID-19 Uncut Sheet

COVID 19宠物原理示意图






  • Previous:
  • Next:

  • Write your message here and send it to us